medigraphic.com
ISSN 1608-8921 (Print)

2011, Number 1

<< Back Next >>

Gaceta Médica Espirituana 2011; 13 (1)

Results of trabeculectomy in glaucoma patients. Sancti Spiritus. 2009

Infante RY, Cabeza ME, Pina GM, Guelmes RN

Language: Spanish
References: 27
Page:
PDF size: 130.48 Kb.


ABSTRACT

Glaucoma is a health problem and is the second leading cause of blindness worldwide after cataract. During the last decades significant progress has been made in the antiglaucoma arsenal. If intraocular pressure is not controlled with medications, surgery is the second choice. Damage to the optic nerve is irreversible, and surgery is suggested before the condition has progressed too much. Objective: To describe the results of trabeculectomy in glaucoma patients operated in the province of Sancti Spiritus in 2009. Methodology: A prospective, descriptive study was made. The population consisted of 72 patients with glaucoma, by performing trabeculectomy in 78 eyes. The data were obtained from medical records. The variables chosen were age, sex, color of skin, risk factors, general personal medical history as well as more common post-operative complications and postoperative ocular pressure. Results: Most patients experienced 61 years of age and older, predominantly male, and skin color not white. Hypertension was the most frequent systemic disease and ocular hypertension major risk factor. The main postoperative complication was hyphaema. Conclusions: The finding of ocular pressure under 18 mmHg in most of the patients after surgery implies that early diagnosis and timely treatment of glaucoma is vital to prevent blindness.


REFERENCES

  1. García J. El Glaucoma en atención primaria. Tiempos Médicos 2003; 98:22-9.

  2. Del Hoyo J, Cassan A. Glaucoma. Compartir 2003; 49: 6-7.

  3. WHO and IAPB. The states of the world´s sight. The Right to Sight 1999-2005. VISION 2020; 2005.

  4. Wenreb RN, Khaw PT. Primary open glaucoma. Lancet 2004; 363:1711- 20.

  5. Labrada Rodríguez G, Flores Pérez D, González Hernández L. Pesquisa de glaucoma juvenil en provincia Las Tunas. Estudio preliminar. Rev. Cubana Oftalmol 2002; 15(1):57-64.

  6. Castillo A. Objetivo del tratamiento del Glaucoma. Tiempos Médicos 2005; 615: 25-33.

  7. García J. Introducción. Tiempos Médicos 2005; 615:11-22.

  8. Palmero Guerra A, Cardoso Hernández C, Arrieta Pérez M, Pérez Aguiar D. Principales causas de ceguera en la provincia de Sancti- Spíritus. Rev. cubana Oftalm 1989; 2(1-2): 71- 7.

  9. Martínez E, Llorca J, Prieto Salcedo D, Fariñas Álvarez C, Churchon MV, Delgado Rodríguez M. Ensayos Clínicos sobre glaucoma, diferencias en función de que evalúen tratamiento médico o quirúrgico. Arch. Soc. Esp. Oftamol 2004; 79(3): 111-8.

  10. Dr. Benjamin F. Boyd, Dr. Maurice Luntz, F.A.C.S. Ultimas innovaciones en los glaucomas, etiología, diagnostico, y tratamiento. 2002 (11).

  11. Bulletin of WHO. 2004;82: 844-85. Gasuil X. Estudiar la función de la red trabecular mejorará el tratamiento del glaucoma. Arch. Soc. Esp. Oftamol 2003; 59(7): 114-8.

  12. González J. Una nueva alternativa al tratamiento de glaucoma de ángulo abierto. CD copyright. 2006.

  13. Schwartz R, Buding D. Current management of glaucoma cur opinion in ophthalmology. Ophthalmology 2004; 15:119-26.

  14. Boyd L, Benjamín MD, Samuel MD. Ultimas innovaciones en los Glaucomas. Etiología, Diagnóstico y Tratamiento. Panamá: Highlights of Ophthalmology. (CD ROM); 2002: 56-80.

  15. Medeiros FA, Weinreb RN, Simple PA. Validation of a predective model to estimate the risk of conversion from ocular hypertension. Am J Ophthalmol. 2005;123:1351-60

  16. Allingham R, Danjii K, Freedman S, Moroi S. Shields´Textbook of glaucoma. Lippincott: Williams and Wilkins. 2005:303-9.

  17. Cantor LB. Basic and clinical science course. Glaucoma. Am Acad Ophthalmol; 2003-2004.

  18. Mermound A, Roy S. Laser treatment in glaucoma. En: Mastering the techniques of glaucoma. Diagnosis and Management. New Delhi: Jayppe Brothers; 2006. p.402-6.

  19. Mead AL, Wong TT, Cordeiro M F, Anderson I , Khaw PP. Evaluation of anti-TGF-Beta 2 antibody as a new postoperative ant scarring agent in glaucoma surgery. lnvest ophthalmol. VIS SCI 2003; 44:3394-401.

  20. Kanski JJ. Glaucoma En: Oftalmología clínica. Madrid: Harcourt 2004: 220-7.

  21. Christopher J, Deckens MD. The developmental glaucoma. En: Duane ophthalmology en CD ROM user guide [monografía en CD ROM Tassman W Jaeger editor’s version 2.0]. Haginston: Lipincolt Rayen 2004.

  22. Ortiz González E, Miqueli Rodríguez M, García González AO. Estudio del área quirúrgica en pacientes trabeculectomizados. Rev. Cubana Oftamol 2000; 13(1):25-9.

  23. Negrete FJ, Rebolleda G, Noval S. Facoesclerectomía profunda no perforante. Resultados y complicaciones. Arch. Soc. Esp. Oftamol 2003; 6: 343- 50.

  24. Wishart M, Shugell T, Porooshani H. Viscocanalostomy and Phacoviscocanalostomy: long term results. J Cataract refractive surgery 2002; 28: 745-51.

  25. González J. SLT, experiencia personal, resultados a 1 año de seguimiento en pacientes operados de glaucoma. CD copyright. 2006

  26. Alpert MG, Laubach JL. Primary angle-closure glaucoma in the American negre. Arch ophtalmology .2003;79:663.

  27. Martínez JM. Tratamiento quirúrgico del Glaucoma. Tiempos Médicos 2005; 615: 34-45.




2020     |     www.medigraphic.com